As PA Week 2026 draws to a close, The Clinical Advisor Editor Maya Blumenfeld joined The Today Show on October 9 to celebrate ...

A pooled analysis of phase 3 ICONIC data demonstrates that concomitant GLP-1 medication use does not alter skin clearance, ...

Multi-country discrete-choice experiment presented at the Fall Clinical Dermatology Conference demonstrates that skin ...

C, MPAS, emphasized the need for more PAs in leadership and the importance of closing gaps in LGBTQ+ health care.

Postpartum initiation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) grew 24-fold from 2018 to 2025, according to a research letter published online in the Journal of the American Medical ...

Panelists highlight major 2026 approvals, novel oral therapies, expanded pediatric indications, and new severity definitions ...

Editors of Dermatology Advisor, Medical Professionals Reference, and Clinical Advisor will be covering key takeaways from the ...

Recognizing non-classic morphological presentations and mitigating diagnostic delays are critical to improving outcomes for patients with darker skin tones.

Ashley Drapeau shared her insights on integrating holistic and Western medicine to treat patients with long COVID and the ...

Assessing conservative and surgical management strategies for patients presenting with exercise-induced lower limb ...

Overall, 46.3 % of the 75,614 youths on Medicaid who engaged in treatment received medications for OUD, representing 15.2% of all youths with OUD.

Researchers evaluated the impact of continuous glucose monitoring threshold and predictive alerts on inpatient glycemic management.